Publication | Closed Access

Inhibition of SGLT2 co-transporter by dapagliflozin ameliorates tubular proteinuria and tubule-interstitial injury at the early stage of diabetic kidney disease

Renal FunctionRenal DiseaseMedicinePhysiologyPharmacologyDiabetesDiabetic Kidney DiseaseSglt2 Co-transporterChronic Kidney DiseaseNephrologyKidney ResearchEarly Stage